AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitel-M 1 Tablet ER

Prescription Icon
Prescription Required

Marketer

L T & L Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimitel-M 1 Tablet ER

Diabeticin-Duo ER, a single-dose tablet, is classified as an antidiabetic medication. This dual-action formulation treats type 2 diabetes in adults by effectively managing blood glucose levels. Diabeticin-Duo ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to lower blood sugar. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended under your doctor's guidance.

Primary Ingredients of Glimitel-M 1 Tablet ER

No text was provided to rewrite.

Uses of Glimitel-M 1 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimitel-M 1 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Take one extended-release Glimitel-M tablet with a meal.

Common Side effects of Glimitel-M 1 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitel-M 1 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take one extended-release Glimitel-M tablet with food.

How Glimitel-M 1 Tablet ER works:

Glimitel-M 1 Extended-Release tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimitel-M 1 Tablet ER and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitel-M 1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimitel-M tablets (1 mg) are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimitel-M 1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Glimitel-M 1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimitel-M 1 Tablet ER to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose of Glimitel-M 1 Tablet ER is typically recommended for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in cases of severe liver disease.

What if you forget to take Glimitel-M 1 Tablet ER :

Should you forget a dose of Glimitel-M 1 Tablet ER, take it immediately if possible. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimitel-M 1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitel-M 1 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitel-M 1 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimitel-M 1 Tablet ER and seek immediate medical attention.
Glimitel-M 1 Tablet ER combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It is not suitable for treating type 1 DM.
Glimitel-M 1 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimitel-M 1 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Glimitel-M 1 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimitel-M 1 Tablet ER and alcohol is unsafe. Alcohol can exacerbate Glimitel-M's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimitel-M 1 Tablet ER
54
MRP 63
14% off